May COVID-19 infection induce a paradoxical improvement of a non-responsive case of hidradenitis suppurativa?

被引：3
|
作者：
Caro, Raffaele D. Caposiena [1 ,2 ]
Pensa, Chiara [1 ]
Lambiase, Sara [1 ]
Candi, Eleonora [2 ]
Bianchi, Luca [1 ]
机构：
[1] Tor Vergata Univ, Dept Dermatol, Dept Syst Med, Viale Oxford 81, I-00133 Rome, Italy
[2] Tor Vergata Univ, Dept Expt Med, Rome, Italy
来源：
ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY | 2021年 / 156卷 / 05期
关键词：
D O I：
10.23736/S2784-8671.21.07076-6
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：616 / 617
页数：2
相关论文
共 50 条
  • [21] Low incidence of COVID-19 in hidradenitis suppurativa: How to interpret it?
    Dewigne, Mathilde
    Orte Cano, Carmen
    Daoud, Mathieu
    del Marmol, Veronique
    Benhadou, Farida
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (03) : 435 - 436
  • [22] Remote management of hidradenitis suppurativa in a pandemic era of COVID-19
    Kang, Na-Young C.
    Hsiao, Jennifer
    Shi, Vivian
    Naik, Haley B.
    Lowes, Michelle A.
    Alavi, Afsaneh
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (09) : E318 - E320
  • [23] Updated findings from the global hidradenitis suppurativa COVID-19 registry
    Naik, Haley B.
    Alhusayen, Raed
    Guilbault, Sandra
    Ingram, John
    Lowes, Michelle A.
    Marzano, Angelo V.
    Villumsen, Bente
    Yannuzzi, Christine
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 55 - 55
  • [24] Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa
    Pakhchanian, Haig
    Raiker, Rahul
    DeYoung, Charles
    Yang, Sherry
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (06) : 1186 - 1188
  • [25] Non-Responsive Infection: A Rare Case of Papillary Adenocarcinoma of the Lung
    Escobar, C. Pinzon
    Onwochei, J.
    Attah, R.
    Patel, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [26] Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa'
    Martora, Fabrizio
    Marasca, Claudio
    Battista, Teresa
    Fabbrocini, Gabriella
    Ruggiero, Angelo
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (11) : 2026 - 2028
  • [27] Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
    Blaszczak, Alecia
    Trinidad, John C. L.
    Cartron, Alexander M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : E31 - E31
  • [28] Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic
    Shah, Monica
    Naik, Haley B.
    Alhusayen, Raed
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : E81 - E82
  • [29] Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic
    Kearns, Donovan G.
    Chat, Vipawee S.
    Uppal, Shelley
    Wu, Jashin J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : E433 - E434
  • [30] Telehealth use at a specialty hidradenitis suppurativa clinic during the COVID-19 pandemic
    Kim, Diana S.
    Kimball, Alexa B.
    Porter, Martina L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB115 - AB115
12345